Pds Planning, Inc Eli Lilly & CO Transaction History

Pds Planning, Inc

$1.1 Billion
Q3 2024

A detailed history of Pds Planning, Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Pds Planning, Inc holds 5,852 shares of LLY stock, worth $4.43 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares

5,852

Previous 5,767 1.47%

Holding current value

$4.43 Million

Previous $5.22 Million 0.71%

% of portfolio

0.47%

Previous 0.53%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$772.14 - $960.02 $65,631 - $81,601	85 Added 1.47%	5,852 $5.18 Million
Q2 2024 Aug 07, 2024	BUY	$724.87 - $909.04 $508,858 - $638,146	702 Added 13.86%	5,767 $5.22 Million
Q1 2024 May 01, 2024	BUY	$592.2 - $792.28 $47,968 - $64,174	81 Added 1.63%	5,065 $3.94 Million
Q4 2023 Feb 01, 2024	BUY	$525.19 - $619.13 $4,726 - $5,572	9 Added 0.18%	4,984 $2.91 Million
Q3 2023 Oct 20, 2023	BUY	$434.7 - $599.3 $36,080 - $49,741	83 Added 1.7%	4,975 $2.67 Million
Q2 2023 Jul 20, 2023	BUY	$350.74 - $468.98 $91,543 - $122,403	261 Added 5.64%	4,892 $2.29 Million
Q1 2023 May 01, 2023	BUY	$310.63 - $364.82 $391,704 - $460,038	1,261 Added 37.42%	4,631 $1.59 Million
Q4 2022 Jan 26, 2023	BUY	$321.55 - $374.67 $4,823 - $5,620	15 Added 0.45%	3,370 $0
Q3 2022 Nov 02, 2022	BUY	$296.48 - $337.87 $3,261 - $3,716	11 Added 0.33%	3,355 $1.09 Million
Q2 2022 Jul 15, 2022	BUY	$278.73 - $327.27 $77,486 - $90,981	278 Added 9.07%	3,344 $1.08 Million
Q1 2022 Apr 18, 2022	BUY	$234.69 - $291.66 $114,528 - $142,330	488 Added 18.93%	3,066 $878,000
Q4 2021 Jan 25, 2022	BUY	$224.85 - $279.04 $4,047 - $5,022	18 Added 0.7%	2,578 $712,000
Q3 2021 Oct 22, 2021	BUY	$221.6 - $272.71 $7,534 - $9,272	34 Added 1.35%	2,560 $591,000
Q2 2021 Jul 26, 2021	BUY	$180.55 - $233.54 $97,677 - $126,345	541 Added 27.25%	2,526 $580,000
Q1 2021 Apr 20, 2021	SELL	$164.32 - $212.72 $1,971 - $2,552	-12 Reduced 0.6%	1,985 $371,000
Q4 2020 Jan 21, 2021	BUY	$130.46 - $172.63 $14,350 - $18,989	110 Added 5.83%	1,997 $337,000
Q3 2020 Oct 19, 2020	BUY	$146.22 - $169.13 $13,744 - $15,898	94 Added 5.24%	1,887 $279,000
Q2 2020 Aug 11, 2020	BUY	$136.42 - $164.18 $35,332 - $42,522	259 Added 16.88%	1,793 $294,000
Q1 2020 Apr 20, 2020	BUY	$119.05 - $147.35 $6,190 - $7,662	52 Added 3.51%	1,534 $213,000
Q4 2019 Feb 07, 2020	BUY	$106.92 - $132.43 $641 - $794	6 Added 0.41%	1,482 $195,000
Q3 2019 Oct 28, 2019	SELL	$106.79 - $116.16 $533 - $580	-5 Reduced 0.34%	1,476 $165,000
Q2 2019 Aug 14, 2019	BUY	$110.79 - $129.32 $164,079 - $191,522	1,481 New	1,481 $164,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $720B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pds Planning, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Pds Planning, Inc with notifications on news.

Account